Literature DB >> 9109910

Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.

A Pestronk1, R Choksi, G Blume, G Lopate.   

Abstract

IgM anti-GM1 antibodies are associated with motor neuropathy syndromes, including multifocal motor neuropathy (MMN). We compared the ability of serum IgM from patients with multifocal motor neuropathy to bind to GM1 ganglioside alone and to GM1 as a component of a lipid mixture that also contained galactocerebroside and cholesterol (GGC). Our results showed that high-titer selective serum IgM binding to GGC has strong specificity for MMN. Further, over 40% more serums from patients with MMN have high-titer serum IgM binding to GGC than to GM1 alone. The specific composition and structure of the lipid mixture altered the ability of serum IgM to bind to GM1 ganglioside. Substitutions of other lipids for galactocerebroside or cholesterol could completely inhibit the antibody binding. We conclude that serum IgM anti-GGC autoantibodies have specificity for MMN and their binding is strongly influenced by the lipid environment of GM1 ganglioside.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109910     DOI: 10.1212/wnl.48.4.1104

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

2.  Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy.

Authors:  F Galban-Horcajo; A M Fitzpatrick; A J Hutton; S M Dunn; G Kalna; K M Brennan; S Rinaldi; R K Yu; C S Goodyear; H J Willison
Journal:  Eur J Neurol       Date:  2012-06-22       Impact factor: 6.089

Review 3.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

Review 4.  Immune pathogenesis and treatment of multifocal motor neuropathy.

Authors:  Lotte Vlam; Leonard H van den Berg; Elisabeth A Cats; Sanne Piepers; W-Ludo van der Pol
Journal:  J Clin Immunol       Date:  2012-09-02       Impact factor: 8.317

5.  Complement activity is associated with disease severity in multifocal motor neuropathy.

Authors:  Lotte Vlam; Elisabeth A Cats; Oliver Harschnitz; Marc D Jansen; Sanne Piepers; Jan Herman Veldink; Hessel Franssen; Abraham C J Stork; Erik Heezius; Suzan H M Rooijakkers; Bjorn L Herpers; Jos A van Strijp; Leonard H van den Berg; W Ludo van der Pol
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-06-25

6.  Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.

Authors:  Delmont Emilien; Willison Hugh
Journal:  J Neuromuscul Dis       Date:  2015-06-04

7.  The Diagnostic Utility of Determining Anti-GM1: GalC Complex Antibodies in Multifocal Motor Neuropathy: A Validation Study.

Authors:  Francesc Galban-Horcajo; Lotte Vlam; Emilien Delmont; Susan K Halstead; Leonard van den Berg; W-Ludo van der Pol; Hugh J Willison
Journal:  J Neuromuscul Dis       Date:  2015-06-04

Review 8.  Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment.

Authors:  Victoria H Lawson; W David Arnold
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-05       Impact factor: 2.570

Review 9.  MMN: from immunological cross-talk to conduction block.

Authors:  Oliver Harschnitz; Bas A Jongbloed; Hessel Franssen; Dirk C G Straver; W Ludo van der Pol; Leonard H van den Berg
Journal:  J Clin Immunol       Date:  2014-04-13       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.